Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease

Stem Cell Res. 2020 Oct:48:101968. doi: 10.1016/j.scr.2020.101968. Epub 2020 Sep 2.

Abstract

A673T mutation in the amyloid precursor protein (APP) is a rare variant associated with a reduced risk of late-onset Alzheimer's disease (AD) and age-related cognitive decline. The A673T mutation decreases beta-amyloid (Aβ) production and aggregation in neuronal cultures in vitro. Here we have identified a Finnish non-diseased male individual carrying a heterozygous A673T mutation, obtained a skin biopsy sample from him, and generated an iPSC line using commercially available integration-free Sendai virus-based kit. The established iPSC line retained the mutation, expressed pluripotency markers, had a normal karyotype, and differentiated into all three germ layers in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / genetics
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor / genetics
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells*
  • Male
  • Mutation

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor